
Rituxan Hycela
My Prescription
Payment
Select pharmacy



$6,795.03
$30.00 due at pharmacy
$6,795.03 - $30.00 = $6,765.03
$6,765.03 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$6,795.03
Print or send this coupon to your phone
About Rituxan Hycela
Drug Details
Rituximab, marketed as Rituxan Hycela, is a medication used to treat specific blood cancers, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, follicular lymphoma, and diffuse large B-cell lymphoma. This drug combines rituximab, an anti-CD20 monoclonal antibody, with hyaluronidase, an enzyme that enhances absorption when administered subcutaneously. Rituximab works by targeting and binding to a protein called CD20 on B cells, which are part of the immune system and may become cancerous. This binding signals the immune system to destroy these abnormal cells, thereby inhibiting their growth and spread. Rituxan Hycela is usually administered every one to three weeks, depending on the patient's condition, and is suitable for individuals who have previously received rituximab intravenously. Potential side effects include allergic reactions, infections, and skin issues.
Price history for Rituxan Hycela
1 Vial, 11.7ML of 1400-23400 MG-UT/11.7ML
Average retail price for Rituxan Hycela
Average SaveHealth price for Rituxan Hycela
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Rituxan Hycela dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 11.7ML of 1400-23400 MG-UT/11.7ML | 1 Vial | $6,795.03 | $6,795.03 |
| 11.7ML of 1400-23400 MG-UT/11.7ML | 2 Vials | $13,582.07 | $6,791.04 |
| 11.7ML of 1400-23400 MG-UT/11.7ML | 3 Vials | $20,369.10 | $6,789.70 |
| 13.4ML of 1600-26800 MG-UT/13.4ML | 1 Vial | $7,764.61 | $7,764.61 |
| 13.4ML of 1600-26800 MG-UT/13.4ML | 2 Vials | $15,521.21 | $7,760.61 |
| 13.4ML of 1600-26800 MG-UT/13.4ML | 3 Vials | $23,277.82 | $7,759.27 |
Rituxan Hycela FAQs
Rituxan Hycela is used for the treatment of certain types of blood cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. It is also used for some autoimmune conditions, such as rheumatoid arthritis.
RITUXAN and RITUXAN HYCELA both contain rituximab, but they differ in their formulation and administration. RITUXAN is administered intravenously, while RITUXAN HYCELA is a subcutaneous injection that combines rituximab with hyaluronidase, an enzyme that helps with absorption under the skin. This allows RITUXAN HYCELA to be administered more quickly compared to the intravenous infusion of RITUXAN.
The cost of RITUXAN HYCELA can vary based on factors such as location, insurance coverage, and the healthcare provider. It is recommended to contact a pharmacy or healthcare provider directly for the most accurate and up-to-date pricing information. Additionally, insurance plans may cover part of the cost, so checking with the insurance provider is advisable.
The generic name for Rituxan Hycela is rituximab and hyaluronidase human.
Rituxan Hycela is not classified as chemotherapy. It is a combination of rituximab, a monoclonal antibody, and hyaluronidase, an enzyme that helps with absorption. Rituximab targets specific proteins on the surface of certain cancer cells and is used in the treatment of certain types of blood cancers and autoimmune diseases.